Kelly A. Kramer - 05 May 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Director
Signature
/s/ Amy Kim by Power of Attorney for Kelly A. Kramer
Issuer symbol
GILD
Transactions as of
05 May 2022
Net transactions value
+$501,684
Form type
4
Filing time
06 May 2022, 18:25:16 UTC
Previous filing
23 Feb 2022
Next filing
24 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Award +2,444 +22% 13,397 05 May 2022 Common Stock 2,444 Direct F1, F2
transaction GILD Non-qualified Stock Option (Right to Buy) Award $501,684 +15,851 $31.65 15,851 05 May 2022 Common Stock 15,851 $61.35 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 100% of the restricted stock units vested immediately upon the grant date of May 5, 2022.
F3 100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022.